These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 3789664

  • 1. Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease.
    Beal MF, Mazurek MF, Svendsen CN, Bird ED, Martin JB.
    Ann Neurol; 1986 Oct; 20(4):489-95. PubMed ID: 3789664
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease.
    Beal MF, Mazurek MF, Ellison DW, Swartz KJ, McGarvey U, Bird ED, Martin JB.
    Ann Neurol; 1988 Jun; 23(6):562-9. PubMed ID: 2900622
    [Abstract] [Full Text] [Related]

  • 5. A postmortem study of amino acid neurotransmitters in Alzheimer's disease.
    Ellison DW, Beal MF, Mazurek MF, Bird ED, Martin JB.
    Ann Neurol; 1986 Nov; 20(5):616-21. PubMed ID: 2878639
    [Abstract] [Full Text] [Related]

  • 6. Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease.
    Beal MF, Mazurek MF, Chattha GK, Svendsen CN, Bird ED, Martin JB.
    Ann Neurol; 1986 Sep; 20(3):282-8. PubMed ID: 3767313
    [Abstract] [Full Text] [Related]

  • 7. Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease.
    Beal MF, Mazurek MF, Tran VT, Chattha G, Bird ED, Martin JB.
    Science; 1985 Jul 19; 229(4710):289-91. PubMed ID: 2861661
    [Abstract] [Full Text] [Related]

  • 8. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.
    Reinikainen KJ, Soininen H, Riekkinen PJ.
    J Neurosci Res; 1990 Dec 19; 27(4):576-86. PubMed ID: 1981917
    [Abstract] [Full Text] [Related]

  • 9. Somatostatin-28(1-12)-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex.
    Beal MF, Benoit R, Mazurek MF, Bird ED, Martin JB.
    Brain Res; 1986 Mar 19; 368(2):380-3. PubMed ID: 2870772
    [Abstract] [Full Text] [Related]

  • 10. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.
    De Souza EB, Whitehouse PJ, Kuhar MJ, Price DL, Vale WW.
    Nature; 1986 Mar 19; 319(6054):593-5. PubMed ID: 3003585
    [Abstract] [Full Text] [Related]

  • 11. Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease.
    Candy JM, Gascoigne AD, Biggins JA, Smith AI, Perry RH, Perry EK, McDermott JR, Edwardson JA.
    J Neurol Sci; 1985 Dec 19; 71(2-3):315-23. PubMed ID: 2868073
    [Abstract] [Full Text] [Related]

  • 12. [Electron-cytochemical study of acetylcholinesterase in the cerebral cortex in Alzheimer's disease].
    Vostrikov VM.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986 Dec 19; 86(7):1003-6. PubMed ID: 3765981
    [Abstract] [Full Text] [Related]

  • 13. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type.
    Dawbarn D, Rossor MN, Mountjoy CQ, Roth M, Emson PC.
    Neurosci Lett; 1986 Sep 25; 70(1):154-9. PubMed ID: 2877420
    [Abstract] [Full Text] [Related]

  • 14. Regional distribution of brain gangliosides in Alzheimer's disease.
    Kalanj S, Kracun I, Rosner H, Cosović C.
    Neurol Croat; 1991 Sep 25; 40(4):269-81. PubMed ID: 1751644
    [Abstract] [Full Text] [Related]

  • 15. Widespread deficits in somatostatin but not neuropeptide Y concentrations in Alzheimer's disease cerebral cortex.
    Gabriel SM, Bierer LM, Harotunian V, Purohit DP, Perl DP, Davis KL.
    Neurosci Lett; 1993 May 28; 155(1):116-20. PubMed ID: 8103205
    [Abstract] [Full Text] [Related]

  • 16. Postmortem studies of peptides in Alzheimer's disease and Huntington's disease.
    Rossor M, Emson P, Dawbarn D, Dockray G, Mountjoy C, Roth M.
    Res Publ Assoc Res Nerv Ment Dis; 1986 May 28; 64():259-77. PubMed ID: 2425405
    [No Abstract] [Full Text] [Related]

  • 17. Cortical abnormalities in Alzheimer's disease.
    Foster NL, Chase TN, Mansi L, Brooks R, Fedio P, Patronas NJ, Di Chiro G.
    Ann Neurol; 1984 Dec 28; 16(6):649-54. PubMed ID: 6335378
    [Abstract] [Full Text] [Related]

  • 18. Possible neurotransmitter basis of behavioral changes in Alzheimer's disease.
    Palmer AM, Stratmann GC, Procter AW, Bowen DM.
    Ann Neurol; 1988 Jun 28; 23(6):616-20. PubMed ID: 2457353
    [Abstract] [Full Text] [Related]

  • 19. A comparison of somatostatin and neuropeptide Y distribution in monkey brain.
    Beal MF, Mazurek MF, Martin JB.
    Brain Res; 1987 Mar 10; 405(2):213-9. PubMed ID: 3567602
    [Abstract] [Full Text] [Related]

  • 20. Cortical somatostatinergic system not affected in Alzheimer's and Parkinson's diseases.
    Whitford C, Candy J, Edwardson J, Perry R.
    J Neurol Sci; 1988 Aug 10; 86(1):13-8. PubMed ID: 2902199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.